(Updated - September 28, 2022 12:44 PM EDT)

Stifel analyst Annabel Samimy downgraded PhaseBio Pharmaceuticals Inc. (NASDAQ: PHAS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE